Objectives
We report a retrospective analysis of clinical and neuroimaging features of surgically treated prolactinoma patients at the University of Southern California (USC) Pituitary Center over the last 2 decades to identify predictors of persistent disease after surgery, with special attention given to identifying predictors of surgical cure as well biochemical control either with or without adjuvant postoperative DA therapy. To supplement our analysis, we conducted a systematic literature review of surgically managed prolactinoma cases through the PubMed database using the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines.[14]
J Endo Soc. 2021;5(10) © 2021 Endocrine Society